Unveiling the Humana-Mays Healthcare Analytics Challenge
Unveiling the Humana-Mays Healthcare Analytics Challenge
Mays Business School at Texas A&M University has collaborated with Humana Inc. to introduce the eagerly anticipated annual healthcare analytics case competition. Now in its eighth iteration, this event invites students to tackle a real-world business problem utilizing their analytical skills. With a compelling prize pool totaling $90,000, this competition offers ample motivation for aspiring analysts. The first-place team will receive $50,000, while second and third places will earn $20,000 and $10,000, respectively. Teams finishing in fourth and fifth places will each receive $5,000.
Who Can Participate?
The competition is designed for full-time and part-time master's students currently enrolled in AACSB-accredited programs across the United States. Eligible programs include Master of Science, Master of Arts, Master of Information Systems, Master of Public Health, and Master of Business Administration, among others. Participants can form teams consisting of two to four members from the same university, creating a collaborative atmosphere for solving pressing business challenges.
Insights from the Organizers
Mays Business School Dean Nate Sharp expressed pride in the partnership with Humana, emphasizing the importance of this competition to future business leaders. "This competition aligns seamlessly with our mission to build a better future through business and highlights the vital role leaders play in advancing innovative healthcare solutions," Sharp noted.
Scott Bagley, PhD, Humana's Vice President of HQRI Technology and Analytics, added depth to the conversation by discussing the rapid advancements in healthcare technology. He articulated that using data-driven strategies significantly enhances the quality and equity of care delivered to patients, which is vital in achieving favorable health outcomes. Bagley further mentioned the value of providing students an opportunity to apply their studies outside of traditional classroom settings, fostering creativity and innovation as they develop impactful solutions to real-world issues.
Evaluation Criteria
As the competition unfolds, teams will be assessed on several key criteria:
- Quantitative analysis that reveals significant business insights.
- Professionalism, including data visualization and presentation skills.
- Ability to derive meaningful implications and recommendations based on the analysis of results and insights.
Important Dates to Remember
This year's competition has several key dates that participants should be aware of:
- September 27: Team registration deadline by 11:59 PM (CST).
- October 1: A virtual Q&A session with competition leadership, offering valuable insights into the competition.
- October 11: Submission deadline for Round One, with Top 50 Teams announced for Round Two.
- October 20: Submission deadline for Round Two.
- November 1: Announcement of the Top 5 Finalists advancing to Round Three.
- November 14: Virtual presentations and announcement of winners.
Past victors of the competition have come from prestigious institutions such as Syracuse University, UCLA, and Georgia Tech, showcasing the caliber of talent this event attracts.
About Mays Business School
Mays Business School is dedicated to shaping a better future through business leadership and education. With more than 6,400 students enrolled in various programs, including accounting, finance, and marketing, Mays consistently ranks among the nation’s top public business schools. The institution is committed to developing principled leaders who contribute positively to their communities.
About Humana Inc.
Humana Inc. strives to prioritize health for its customers and employees alike. Through their insurance services and innovative care initiatives, Humana has made significant strides in improving health outcomes for diverse populations, including those with Medicare and Medicaid. Their continued commitment to enhancing the quality of care makes them a frontrunner in the healthcare industry.
Frequently Asked Questions
What is the Humana-Mays Healthcare Analytics Case Competition?
This competition is an annual event where students apply analytical skills to solve real-world healthcare business problems and compete for prizes.
Who can enter the competition?
Full-time and part-time master's students from AACSB-accredited programs in the U.S. are eligible to participate, forming teams of two to four.
What are the main criteria for judging?
Teams are evaluated on quantitative analysis, professionalism, data visualization, presentation skills, and the implications of their findings.
How much money can teams win?
The prize pool for the competition totals $90,000, with substantial awards for the top five teams.
When are the key dates for the 2024 competition?
Key dates include team registration by September 27, Q&A on October 1, and various submission deadlines through November 14.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- The Rise of Home Equity Loans Among Cash-Strapped Households
- Scam Alert: Understanding the Threat of Online Fraud
- CrowdStrike Holdings, Inc. Faces Important Legal Challenge
- Walmart's Flipkart Faces Legal Challenge Over Antitrust Issues
- Examining China's Economic Strategies and Their Limitations
- Exploring Underrated Healthcare Stocks for Smart Investors
- Exploring the Growth of Actively Managed ETFs in Finance
- Exploring the Dark Side of Crypto: Key Figures Behind Bars
- Sanyou Bio Unveils State-of-the-Art R&D Facility for Innovation
- Join the Legal Action: Stellantis N.V. and Investor Rights
Recent Articles
- In-Depth Analysis of AMD Compared to Semiconductor Rivals
- U.S. Postal Service Introduces Special Hanukkah Stamp for 2024
- Dataocean AI Unveils Premium Datasets at Interspeech 2024
- Wilson Language Training and Vivido Unite to Enhance Literacy
- Analyzing AbbVie: A Comprehensive Look at Biotechnology Rivals
- Toyota Motor North America Champions Health Recovery Initiatives
- Leadership Expansion at CNM LLP with Chris Montgomery's Role
- WETH Surges Over 5% in 24 Hours - A Positive Shift
- Lincoln Property Company Enhances Sustainability Leadership Team
- Florida's Housing Market Shows Positive Trends Amid Changes
- Significant Surge in Wrapped stETH Price Over 24 Hours
- Eco-Friendly Second Crop Corn: A Path to Sustainable Energy
- Aptos Experiences Impressive Price Surge Over 24 Hours
- Dizzion Recognized as a Leader in Desktop as a Service Solutions
- Litecoin Soars Over 3% in 24 Hours: Current Trends and Insights
- Edgewise Therapeutics Boosts Price Target Amid Positive Data
- Balance Point Strengthens Position with BenefitHub Investment
- Legal Confrontation over Stolen Home Ownership Rights
- TraceLink Unveils Revolutionary No-Code Supply Chain Tool
- T-Mobile US: Elevated Projections and Promising Future Ahead
- Quantiphi Honored as Leading Insurtech Company for AI Innovation
- Healthcare Businesswomen's Association Welcomes New CFO
- Leadership Changes at European Wax Center: What You Need to Know
- Safe-Guard Products International Names New COO for Growth
- Coliseum Acquisition Corp. Prepares for Key Shareholder Vote
- IPv4.Global Unveils Comprehensive Leasing Hub for Businesses
- Versus Systems Faces Challenges Amid 52-Week Low Stock Prices
- CVS Health Declares Dividend for Shareholders in New Announcement
- LGL Group Annual Stockholder Meeting Details and Insights
- Unity Wallet Enhances User Experience with Rebranding and Rewards Program
- GAMCO Investors Declares Significant $2.00 Special Dividend
- Empowering Voters 50 Plus: A Call to Action
- Caesars Entertainment Unveils New Mobile Sports Betting App
- Slick City Action Park's Expansion: 50 Locations and Growing
- US Steel Remains Confident with Overweight Rating and Earnings Outlook
- Emerging Capex Cycle Set to Propel SMID Stocks for Growth
- Market Trends: Analyzing Israel's Stock Performance Today
- Norway Stock Market Update: Key Gains and Losses Explained
- Director Transactions and Positive Trends at Fidelity National Financial
- Live Nation Responds to Legal Challenges Over Ticketing Practices
- Reneo Pharmaceuticals Executive Makes Significant Stock Purchase
- Bollinger Bands Creator Shares Insight on Recent Fed Rate Cut
- Wall Street Soars as Rate Cuts Propel Stock Market
- New Partnership Offers USDC/EURC Money Market Access for Clients
- Amazon's Bold Move: A Return to Office Policy Explained
- Robust Growth Projections for the Aseptic Sampling Market
- Earlyworks Partners with CAICA DIGITAL to Enhance Web3 Ventures
- David Ahonen's Notable Transactions at Harvia Plc Unveiled
- Endeavour Mining's Recent Share Transactions by Executives
- Exploring the Recent Decline of Vivos Therapeutics Stock